Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NovoCure Limited
NVCR | US
12.47
USD-0.12
-0.95%
NVCR | US
Loading StockChartView...
About NovoCure Limited
Sector
Industry
Earnings date
30/06/2024
As of date
24/04/2026
Close
12.47
Open
12.69
High
12.80
Low
12.31
NovoCure Limited an oncology company engages in the development manufacture and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States Europe the Middle East Africa Japan and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases gastric cancer glioblastoma liver cancer non-small cell lung cancer pancreatic cancer and ovarian cancer. The company was incorporated in 2000 and is headquartered in Saint Helier Jersey.
View LessNVCR | US
Risk
62.5
Sharpe
-0.51
Luna's Score
46/100
Recommendation
Hold
Luna says (NVCR | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
65.8%1 month
62.5%3 months
93.3%6 months
75.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
909.09
Price to book
5.06
Debt to equity
1.87
Debt to assets
0.56
Ent. to EBITDA
-6.92
Ent. to rev.
2.82
PEG
-0.47
Other Fundamentals
EBITDA
-166.42M
MarketCap
1.35B
MarketCap(USD)
1.35B
Div. yield
-
Op. margin
-22.35
Erngs. growth
-6.00
Rev. growth
19.30
Ret. on equity
-43.40
Short ratio
5.67
Short perc.
6.06
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
2.76
Range1M
3.02
Range3M
5.64
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.64
Price X volume
8.68M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.92 | - | - |
| Ent. to Revenue | 2.82 | - | - |
| PE Ratio | - | - | - |
| Price to Book | 5.06 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 93.34 | - | - |
| Debt to Equity | 1.87 | - | - |
| Debt to Assets | 0.56 | - | - |
| Market Cap | 1.35B | - | - |
